Proteomics and phosphoproteomics analysis of tissues for the reoccurrence prediction of colorectal cancer

References

• Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424.
   PubMed Web of Science ®Google Scholar
• Peltrini R, Sacco M, Luglio G, et al. Local excision following chemoradiotherapy in T2-T3 rectal cancer: current status and critical appraisal. Updates Surg. 2020;72(1):29–37.
   PubMed Web of Science ®Google Scholar
• Fischer J, Walker LC, Robinson BA, et al. Clinical implications of the genetics of sporadic colorectal cancer. ANZ J Surg. 2019;89(10):1224–1229.
   PubMed Web of Science ®Google Scholar
• Reece MM, Chapuis PH, Keshava A, et al. When does curatively treated colorectal cancer recur? An Australian perspective. ANZ J Surg. 2018;88(11):1163–1167.
   PubMed Web of Science ®Google Scholar
• van der Stok EP, Spaander M, Grunhagen DJ, et al. Surveillance after curative treatment for colorectal cancer. Nat Rev Clin Oncol. 2017;14(5):297–315.
   PubMed Web of Science ®Google Scholar
• Walker AS, Johnson EK, Maykel JA, et al. Future directions for the early detection of colorectal cancer recurrence. J Cancer. 2014;5(4):272–280.
   PubMed Web of Science ®Google Scholar
• Bockelman C, Engelmann BE, Kaprio T, et al. Risk of recurrence in patients with colon cancer stage II and III: a systematic review and meta-analysis of recent literature. Acta Oncol. 2015;54(1):5–16.
   PubMed Web of Science ®Google Scholar
• Rebuzzi SE, Pesola G, Martelli V, et al. Adjuvant chemotherapy for stage II colon cancer. Cancers (Basel). 2020;12(9):2584.
   PubMed Web of Science ®Google Scholar
• Kanwar SS, Poolla A, Majumdar AP, et al. Regulation of colon cancer recurrence and development of therapeutic strategies. World J Gastrointest Pathophysiol. 2012;3(1):1–9.
   PubMedGoogle Scholar
• Patriarca S, Ferretti S, Zanetti R. TNM classification of malignant tumours - eighth edition: which news? Epidemiol Prev. 2017;41(2):140–143.
   PubMed Web of Science ®Google Scholar
• Ting WC, Chen LM, Pao JB, et al. Common genetic variants in Wnt signaling pathway genes as potential prognostic biomarkers for colorectal cancer. PLoS One. 2013;8(2):e56196.
   PubMed Web of Science ®Google Scholar
• Bupathi M, Wu C. Biomarkers for immune therapy in colorectal cancer: mismatch-repair deficiency and others. J Gastrointest Oncol. 2016;7(5):713–720.
   PubMedGoogle Scholar
• Maguire A, Sheahan K. Controversies in the pathological assessment of colorectal cancer. World J Gastroenterol. 2014;20(29):9850–9861.
   PubMed Web of Science ®Google Scholar
• Dekker E, Tanis PJ, Vleugels J, et al. Colorectal cancer. Lancet. 2019;394(10207):1467–1480.
   PubMed Web of Science ®Google Scholar
• Abyadeh M, Meyfour A, Gupta V, et al. Recent advances of functional proteomics in gastrointestinal cancers- a path towards the identification of candidate diagnostic, prognostic, and therapeutic molecular biomarkers. Int J Mol Sci. 2020;21(22):8532.
   PubMed Web of Science ®Google Scholar
• Humphrey SJ, James DE, Mann M. Protein phosphorylation: a major switch mechanism for metabolic regulation. Trends Endocrinol Metab. 2015;26(12):676–687.
   PubMed Web of Science ®Google Scholar
• Surmen MG, Surmen S, Ali A, et al. Phosphoproteomic strategies in cancer research: a minireview. Analyst. 2020;145(22):7125–7149.
   PubMed Web of Science ®Google Scholar
• Singh V, Ram M, Kumar R, et al. Phosphorylation: implications in cancer. Protein J. 2017;36(1):1–6.
   PubMed Web of Science ®Google Scholar
• Chen Y, Wang F, Xu F, et al. Mass spectrometry-based protein quantification. Adv Exp Med Biol. 2016;919:255–279.
   PubMed Web of Science ®Google Scholar
• Di Falco MR. Mass spectrometry-based proteomics. Methods Mol Biol. 2018;1775:93–106.
   PubMedGoogle Scholar
• Zhou H, Ye M, Dong J, et al. Robust phosphoproteome enrichment using monodisperse microsphere-based immobilized titanium (IV) ion affinity chromatography. Nat Protoc. 2013;8(3):461–480.
   PubMed Web of Science ®Google Scholar
• Wang Z, Chu H, Yang K, et al. Label-free quantitative proteomics analysis of the sorafenib resistance in hepg2 cells. J Anal Test. 2022;6(3):308–317.
   Web of Science ®Google Scholar
• Tyanova S, Temu T, Sinitcyn P, et al. The Perseus computational platform for comprehensive analysis of (prote)omics data. Nat Methods. 2016;13(9):731–740.
   PubMed Web of Science ®Google Scholar
• Ruprecht B, Lemeer S. Proteomic analysis of phosphorylation in cancer. Expert Rev Proteomics. 2014;11(3):259–267.
   PubMed Web of Science ®Google Scholar
• Day EK, Sosale NG, Lazzara MJ. Cell signaling regulation by protein phosphorylation: a multivariate, heterogeneous, and context-dependent process. Curr Opin Biotechnol. 2016;40:185–192.
   PubMed Web of Science ®Google Scholar
• Gresko E, Ritterhoff S, Sevilla-Perez J, et al. PML tumor suppressor is regulated by HIPK2-mediated phosphorylation in response to DNA damage. Oncogene. 2009;28(5):698–708.
   PubMed Web of Science ®Google Scholar
• Li Y, Sun R, Zou J, et al. Dual roles of the AMP-activated protein kinase pathway in angiogenesis. Cells-Basel. 2019;8(7):752.
   PubMed Web of Science ®Google Scholar
• Colaert N, Helsens K, Martens L, et al. Improved visualization of protein consensus sequences by iceLogo. Nat Methods. 2009;6(11):786–787.
   PubMed Web of Science ®Google Scholar
• Sudol M, Hunter T. NeW wrinkles for an old domain. Cell. 2000;103(7):1001–1004.
   PubMed Web of Science ®Google Scholar
• Kops O, Zhou XZ, Lu KP. Pin1 modulates the dephosphorylation of the RNA polymerase II C-terminal domain by yeast Fcp1. FEBS Lett. 2002;513(2–3):305–311.
   PubMed Web of Science ®Google Scholar
• Roskoski RJ. ERK1/2 MAP kinases: structure, function, and regulation. Pharmacol Res. 2012;66(2):105–143.
   PubMed Web of Science ®Google Scholar
• Manning BD, Cantley LC. AKT/PKB signaling: navigating downstream. Cell. 2007;129(7):1261–1274.
   PubMed Web of Science ®Google Scholar
• Kramer A, Green J, Pollard JJ, et al. Causal analysis approaches in ingenuity pathway analysis. Bioinformatics. 2014;30(4):523–530.
   PubMed Web of Science ®Google Scholar
• Deng Y, Kurland BF, Wang J, et al. High epidermal growth factor receptor expression in metastatic colorectal cancer lymph nodes may be more prognostic of poor survival than in primary tumor. Am J Clin Oncol. 2009;32(3):245–252.
   PubMed Web of Science ®Google Scholar
• Kaczkowski B, Tanaka Y, Kawaji H, et al. Transcriptome analysis of recurrently deregulated genes across multiple cancers identifies new pan-cancer biomarkers. Cancer Res. 2016;76(2):216–226.
   PubMed Web of Science ®Google Scholar
• Li Y, Du H, Qin Y, et al. Activation of the signal transducers and activators of the transcription 3 pathway in alveolar epithelial cells induces inflammation and adenocarcinomas in mouse lung. Cancer Res. 2007;67(18):8494–8503.
   PubMed Web of Science ®Google Scholar
• Hever A, Roth RB, Hevezi PA, et al. Molecular characterization of human adenomyosis. Mol Hum Reprod. 2006;12(12):737–748.
   PubMed Web of Science ®Google Scholar
• Nomura T. Hidradenitis suppurativa as a potential subtype of autoinflammatory keratinization disease. Front Immunol. 2020;11:847.
   PubMed Web of Science ®Google Scholar
• Fujinaga K. P-TEFb as A promising therapeutic target. Molecules. 2020;25(4):838.
   PubMed Web of Science ®Google Scholar
• Kaur A, Westermarck J. Regulation of protein phosphatase 2A (PP2A) tumor suppressor function by PME-1. Biochem Soc Trans. 2016;44(6):1683–1693.
   PubMedGoogle Scholar
• Dacol EC, Wang S, Chen Y, et al. The interaction of SET and protein phosphatase 2A as target for cancer therapy. Biochim Biophys Acta Rev Cancer. 2021;1876(1):188578.
   PubMed Web of Science ®Google Scholar
• Patrao AS, Dias F, Teixeira AL, et al. XPO5 genetic polymorphisms in cancer risk and prognosis. Pharmacogenomics. 2018;19(9):799–808.
   PubMed Web of Science ®Google Scholar
• Zhou W, Li J, Lu X, et al. Derivation and validation of a prognostic model for cancer dependency genes based on CRISPR-Cas9 in gastric adenocarcinoma. Front Oncol. 2021;11:617289.
   PubMedGoogle Scholar
• Wang P, Zheng H, Zhang J, et al. Identification of key gene modules and genes in colorectal cancer by co-expression analysis weighted gene co-expression network analysis. Biosci Rep. 2020;40(9):R20202044.
   Google Scholar
• Chen R, Zhu J, Dong Y, et al. Suppressor of Ty homolog-5, a novel tumor-specific human telomerase reverse transcriptase promoter-binding protein and activator in colon cancer cells. Oncotarget. 2015;6(32):32841–32855.
   PubMedGoogle Scholar
• Ceccarelli DF, Ivantsiv S, Mullin AA, et al. FAM105A/OTULINL is a pseudodeubiquitinase of the OTU-Class that localizes to the ER membrane. Structure. 2019;27(6):1000–1012.
   PubMed Web of Science ®Google Scholar
• Veiga-da-Cunha M, Chevalier N, Stroobant V, et al. Metabolite proofreading in carnosine and homocarnosine synthesis: molecular identification of PM20D2 as beta-alanyl-lysine dipeptidase. J Biol Chem. 2014;289(28):19726–19736.
   PubMed Web of Science ®Google Scholar
• Pawlowski KM, Maciejewski H, Majchrzak K, et al. Five markers useful for the distinction of canine mammary malignancy. BMC Vet Res. 2013;9:138.
   PubMed Web of Science ®Google Scholar
• Naik S, Dothager RS, Marasa J, et al. Vascular endothelial growth factor receptor-1 is synthetic lethal to aberrant {beta}-catenin activation in colon cancer. Clin Cancer Res. 2009;15(24):7529–7537.
   PubMed Web of Science ®Google Scholar
• Ardeljan D, Taylor MS, Ting DT, et al. The human long interspersed element-1 retrotransposon: an emerging biomarker of neoplasia. Clin Chem. 2017;63(4):816–822.
   PubMed Web of Science ®Google Scholar
• Crawford NP, Yang H, Mattaini KR, et al. The metastasis efficiency modifier ribosomal RNA processing 1 homolog B (RRP1B) is a chromatin-associated factor. J Biol Chem. 2009;284(42):28660–28673.
   PubMed Web of Science ®Google Scholar
• McCann TS, Parrish JK, Hsieh J, et al. KDM5A and PHF2 positively control expression of pro-metastatic genes repressed by EWS/Fli1, and promote growth and metastatic properties in Ewing sarcoma. Oncotarget. 2020;11(43):3818–3831.
   PubMedGoogle Scholar
• Ma F, Bi L, Yang G, et al. ZNF703 promotes tumor cell proliferation and invasion and predicts poor prognosis in patients with colorectal cancer. Oncol Rep. 2014;32(3):1071–1077.
   PubMed Web of Science ®Google Scholar
• Walter SA, Cutler RJ, Martinez R, et al. Stk10, a new member of the polo-like kinase kinase family highly expressed in hematopoietic tissue. J Biol Chem. 2003;278(20):18221–18228.
   PubMed Web of Science ®Google Scholar
• Zheng X, Xu H, Gong L, et al. Vinculin orchestrates prostate cancer progression by regulating tumor cell invasion, migration, and proliferation. Prostate. 2021;81(6):347–356.
   PubMed Web of Science ®Google Scholar
• Mussazhanova Z, Akazawa Y, Matsuda K, et al. Association between p53-binding protein 1 expression and genomic instability in oncocytic follicular adenoma of the thyroid. Endocr J. 2016;63(5):457–467.
   PubMed Web of Science ®Google Scholar
• Ranjpour M, Wajid S, Jain SK. Elevated expression of sepiapterin reductase, regulator of G protein signaling 1, hypothetical protein CXorf58 homolog, and zinc finger and BTB domain-containing protein 21 isoform X2 is associated with progression of hepatocellular carcinoma. Protoplasma. 2021;258(5):1133–1143.
   PubMed Web of Science ®Google Scholar
• Notas G, Kampa M, Pelekanou V, et al. Whole transcriptome analysis of the ERalpha synthetic fragment P295-T311 (ERalpha17p) identifies specific ERalpha-isoform (ERalpha, ERalpha36)-dependent and -independent actions in breast cancer cells. Mol Oncol. 2013;7(3):595–610.
   PubMed Web of Science ®Google Scholar
• Lawson JS, Field AS, Champion S, et al. Low oestrogen receptor alpha expression in normal breast tissue underlies low breast cancer incidence in Japan. Lancet. 1999;354(9192):1787–1788.
   PubMed Web of Science ®Google Scholar
• Sun Z, Ou C, Liu J, et al. YAP1-induced MALAT1 promotes epithelial-mesenchymal transition and angiogenesis by sponging miR-126-5p in colorectal cancer. Oncogene. 2019;38(14):2627–2644.
   PubMed Web of Science ®Google Scholar
• Foster CT, Gualdrini F, Treisman R. Mutual dependence of the MRTF-SRF and YAP-TEAD pathways in cancer-associated fibroblasts is indirect and mediated by cytoskeletal dynamics. Genes Dev. 2017;31(23–24):2361–2375.
   PubMed Web of Science ®Google Scholar
• De Roock W, De Vriendt V, Normanno N, et al. BRAF, PIK3CA, and PTEN mutations: implications for targeted therapies in metastatic colorectal cancer. Lancet Oncol. 2011;12(6):594–603.
   PubMed Web of Science ®Google Scholar
• Gerritsen ME, Tomlinson JE, Zlot C, et al. Using gene expression profiling to identify the molecular basis of the synergistic actions of hepatocyte growth factor and vascular endothelial growth factor in human endothelial cells. Br J Pharmacol. 2003;140(4):595–610.
   PubMed Web of Science ®Google Scholar